ARWR: Arrowhead Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ARWR: Arrowhead Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,228.15
Enterprise Value ($M) 2,936.04
Book Value ($M) 56.08
Book Value / Share 0.44
Price / Book 39.74
NCAV ($M) -387.08
NCAV / Share -3.07
Price / NCAV -5.76

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -1.02
Return on Equity (ROE) -3.68

Liquidity (mrq)
Quick Ratio 6.09
Current Ratio 6.09

Balance Sheet (mrq) ($M)
Current Assets 570.54
Assets 1,013.69
Liabilities 957.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.55
Operating Income -601.08
Net Income -599.49
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -462.85
Cash from Investing -420.07
Cash from Financing 870.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13D Sarepta Therapeutics, Inc. 9.50
02-14 13G/A Avoro Capital Advisors LLC 9.60 35.32
02-05 13G State Street Corp 4.80 -5.32
04-10 13G/A Vanguard Group Inc 10.01 16.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 287,474 1,114,557 25.79
2025-03-06 271,107 942,025 28.78
2025-03-05 275,021 1,107,921 24.82
2025-03-04 484,690 2,142,959 22.62

(click for more detail)

Similar Companies
APLS – Apellis Pharmaceuticals, Inc. ARQT – Arcutis Biotherapeutics, Inc.
ARVN – Arvinas, Inc. ASMB – Assembly Biosciences, Inc.
ATHA – Athira Pharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Arrowhead Pharmaceuticals